BrightEdge — 2023 Investments

1 investments dated 2023 · listed companies and verified rows first · show all

Modifi Biosciencesmodifibio.com in 𝕏Oct 2023

Modifi Bio presents itself as a research-focused biopharmaceutical company developing medicines and vaccines.

BiotechHealthtechNew Haven, US

Ranjit Bindra(Director)inKingson Lin(Cofounder)in Kevin L. Rakin(Executive Officer, Director)in

BoardLucas de Breed(Director)Kat Kayser-Bricker(Director)

Co-investorsConnecticut Innovations HighCape Capital Pathway Bioventures Advantage Capital Partners Ironwood Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.